selenoneine: isolated from the blood of bluefin tuna, Thunnus orientalis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
selenoneine : A histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine substituted by a selenoxo group at position 2 on the imidazole ring. A selenium-containing antioxidant found in tuna blood. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 86289064 |
CHEBI ID | 79071 |
MeSH ID | M0547595 |
Synonym |
---|
CHEBI:79071 |
selnoneine thione |
selenoergothioneine |
2-selenyl-n(alpha),n(alpha),n(alpha)-trimethyl-l-histidine |
selenoneine |
(2s)-3-(2-selenoxo-2,3-dihydro-1h-imidazol-4-yl)-2-(trimethylazaniumyl)propanoate |
1238388-56-1 |
(alphas)-alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-selenoxo-1h-imidazole-4-ethanaminium inner salt |
Selenoneine is an ergothioneine analog with greater antioxidant activity. It is the major form of organic selenium in the blood, muscles, and other tissues of tuna.
Excerpt | Reference | Relevance |
---|---|---|
"Selenoneine is an ergothioneine analog with greater antioxidant activity and is the major form of organic selenium in the blood, muscles, and other tissues of tuna. " | ( Dietary Supplementation of Selenoneine-Containing Tuna Dark Muscle Extract Effectively Reduces Pathology of Experimental Colorectal Cancers in Mice. Masuda, J; Seko, T; Umemura, C; Yamashita, M; Yamashita, Y; Yamauchi, K; Yokozawa, M, 2018) | 2.22 |
Excerpt | Reference | Relevance |
---|---|---|
"Selenoneine has been speculated to exhibit similar effects." | ( Biosynthesis and isolation of selenoneine from genetically modified fission yeast. Francesconi, KA; Jensen, KB; Kroepfl, N; Kroutil, W; Kuehnelt, D; Reiter, TC; Schwerdtle, T; Turrini, NG, 2018) | 1.49 |
Excerpt | Reference | Relevance |
---|---|---|
"Selenoneine is likely to pass the intestinal barrier via transcellular, carrier-mediated transport, is highly bioavailable to Caco-2 cells and undergoes metabolic transformations." | ( Side-Directed Transfer and Presystemic Metabolism of Selenoneine in a Human Intestinal Barrier Model. Bornhorst, J; Kroepfl, N; Kuehnelt, D; Rohn, I; Schwerdtle, T, 2019) | 2.21 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 14 (63.64) | 24.3611 |
2020's | 8 (36.36) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (32.45) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (4.55%) | 5.53% |
Reviews | 1 (4.55%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 20 (90.91%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |